WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007006790) COMBINATION OF A DPP-IV INHIBITOR AND A CANNABINOID CB1 RECEPTOR ANTAGONIST
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/006790    International Application No.:    PCT/EP2006/064117
Publication Date: 18.01.2007 International Filing Date: 11.07.2006
IPC:
A61K 31/401 (2006.01), A61K 31/454 (2006.01), A61K 45/06 (2006.01), A61P 3/00 (2006.01), A61P 3/04 (2006.01), A61P 3/10 (2006.01), A61P 25/30 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35, CH-4056 Basel (CH) (For All Designated States Except US).
MILOSAVLJEVIC-RISTIC, Smiljana [AT/CH]; (CH) (For US Only)
Inventors: MILOSAVLJEVIC-RISTIC, Smiljana; (CH)
Agent: LIGIBEL, Jean-Marc; NOVARTIS AG, Lichtstrasse 35, CH-4056 Basel (CH)
Priority Data:
60/698,304 12.07.2005 US
Title (EN) COMBINATION OF A DPP-IV INHIBITOR AND A CANNABINOID CB1 RECEPTOR ANTAGONIST
(FR) COMBINAISON DE COMPOSES ORGANIQUES
Abstract: front page image
(EN)The present invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, comprising of a DPP IV inhibitor or a pharmaceutically acceptable salt thereof and comprising at least one CB1 antagonist, or a pharmaceutically acceptable salt thereof. The present invention furthermore relates to the use of such a combination for the prevention of, delay of progression of, treatment of diseases and disorders that may be inhibited by DPP IV inhibition, appetency disorders or substance abuse disorders.
(FR)L'invention concerne une combinaison, telle qu'une préparation combinée ou une composition pharmaceutique, respectivement, constituée d'un inhibiteur de la DPP IV ou d'un sel pharmaceutiquement acceptable de celui-ci et d'au moins un antagoniste des récepteurs CB1 ou d'un sel pharmaceutiquement acceptable de celui/ceux-ci. L'invention concerne de plus l'utilisation de cette combinaison pour prévenir, retarder la progression ou traiter des maladies et des troubles pouvant être inhibés par l'inhibition de la DPP IV, des troubles de l'appétit ou des troubles liés à l'abus d'alcool ou d'autres drogues.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)